BlackRock Investment Management’s Novavax NVAX Stock Holding History

BlackRock Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.28M	Sell	50,652 -75	-0.1%	-$2.19K	﹤0.01%	2537
2016 Q3	$2.11M	Buy	50,727 +443	+0.9%	+$57.2K	﹤0.01%	2115
2016 Q2	$7.31M	Buy	50,284 +3,663	+8%	+$420K	0.01%	1165
2016 Q1	$4.81M	Buy	46,621 +1,729	+4%	+$185K	0.01%	1405
2015 Q4	$7.53M	Buy	44,892 +208	+0.5%	+$32K	0.01%	1108
2015 Q3	$6.32M	Sell	44,684 -708	-2%	-$159K	0.01%	1214
2015 Q2	$10.1M	Buy	45,392 +12,520	+38%	+$2.2M	0.01%	1011
2015 Q1	$5.44M	Buy	32,872 +486	+2%	+$78.9K	0.01%	1307
2014 Q4	$3.84M	Sell	32,386 -158	-0.5%	-$16.5K	0.01%	1568
2014 Q3	$2.71M	Buy	32,544 +3,983	+14%	+$360K	﹤0.01%	1775
2014 Q2	$2.64M	Buy	28,561 +2,766	+11%	+$243K	﹤0.01%	1860
2014 Q1	$2.34M	Buy	25,795 +330	+1%	+$36.9K	﹤0.01%	1932
2013 Q4	$2.61M	Buy	25,465 +6,378	+33%	+$451K	﹤0.01%	1843
2013 Q3	$1.2M	Buy	19,087 +1,387	+8%	+$78.1K	﹤0.01%	2315
2013 Q2	$726K	Buy	+17,700	New	+$767K	﹤0.01%	2599

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

QIM

Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Investment Management's NVAX Position: Q4 2016 in Review

BlackRock Investment Management reduced its Novavax (NVAX) stake by 0.15% in Q4 2016, selling an estimated $2.19K and leaving 50,652 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

BlackRock Investment Management first reported a position in NVAX in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.1M in Q2 2015. 143 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

BlackRock Investment Management held 50,652 shares of Novavax worth $1.28M as of Q4 2016.
BlackRock Investment Management sold 75 Novavax shares in Q4 2016, an estimated $2.19K.
Novavax made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2537 holding.
BlackRock Investment Management first reported a position in Novavax in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Novavax position peaked at $10.1M in Q2 2015.
143 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.